Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCTA Study of Timolol vs Brimonidine in Glaucoma
NCT03323164Phase 4Completed
- Sponsor
- Wills Eye Hospital
- Start
- Jul 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of timolol, brimonidine in primary open-angle glaucoma (POAG), normal tension glaucoma (NTG), ocular hypertension, sponsored by Wills Eye Hospital. Started Jul 2017; status: completed.
02
Drugs
timololbrimonidine
03
Conditions
primary open-angle glaucoma (POAG)normal tension glaucoma (NTG)ocular hypertension
Beyond the preview
Go deeper on NCT03323164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03323164.